Gufic BioSciences
Gufic Biosciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Gufic BioSciences
Start SIPGufic Biosciences Investment Rating
-
Master Rating:
-
Gufic Biosciences has an operating revenue of Rs. 679.78 Cr. on a trailing 12-month basis. An annual revenue growth of 59% is outstanding, Pre-tax margin of 16% is great, ROE of 35% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 177 | 175 | 165 | 162 |
| Operating Expenses Qtr Cr | 144 | 142 | 132 | 131 |
| Operating Profit Qtr Cr | 33 | 33 | 33 | 32 |
| Depreciation Qtr Cr | 5 | 5 | 4 | 4 |
| Interest Qtr Cr | 2 | 2 | 1 | 1 |
| Tax Qtr Cr | 7 | 7 | 7 | 6 |
| Net Profit Qtr Cr | 20 | 20 | 21 | 20 |
Gufic Biosciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 201.22
- 50 Day
- 208.28
- 100 Day
- 212.56
- 200 Day
- 214.43
- 20 Day
- 202.82
- 50 Day
- 211.53
- 100 Day
- 214.72
- 200 Day
- 215
Gufic Biosciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 197.1 |
| Second Resistance | 200.2 |
| Third Resistance | 202.1 |
| RSI | 29.27 |
| MFI | 30.5 |
| MACD Single Line | -4.51 |
| MACD | -5.34 |
| Support | |
|---|---|
| First Resistance | 192.1 |
| Second Resistance | 190.2 |
| Third Resistance | 187.1 |
Gufic Biosciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 59,178 | 4,068,488 | 68.75 |
| Week | 64,115 | 3,656,490 | 57.03 |
| 1 Month | 74,056 | 4,324,865 | 58.4 |
| 6 Month | 115,873 | 5,998,743 | 51.77 |
Gufic Biosciences Result Highlights
Gufic BioSciences Synopsis
NSE-Medical-Generic Drugs
Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 779.16 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2022. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.| Market Cap | 1,843 |
| Sales | 680 |
| Shares in Float | 2.42 |
| No of funds | 11 |
| Yield | 0.05 |
| Book Value | 6.85 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 18 |
| Alpha | -0.07 |
| Beta | 0.71 |
Gufic BioSciences
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 75% | 75% | 75% | |
| Mutual Funds | 1.03% | 1.03% | 1.03% | |
| Foreign Portfolio Investors | 0.16% | 0.06% | 1.38% | |
| Individual Investors | 18.24% | 18.28% | 17.84% | |
| Others | 5.57% | 5.63% | 4.75% |
Gufic BioSciences Management
| Name | Designation |
|---|---|
| Mr. Jayesh P Choksi | Chairman & Managing Director |
| Mr. Pranav J Choksi | WholeTime Director & CEO |
| Mr. Pankaj J Gandhi | Whole Time Director |
| Mr. Dilip B Ghosh | Whole Time Director |
| Dr. Balram H Singh | Non Exe.Non Ind.Director |
| Mr. Rabi N Sahoo | Independent Director |
| Mr. Gopal M Daptari | Independent Director |
| Mr. Shreyas K Patel | Independent Director |
| Mr. Shrirang V Vaidya | Independent Director |
| Dr. Anu S Auora | Independent Director |
Gufic Biosciences Forecast
Price Estimates
Gufic BioSciences FAQs
What is Share Price of Gufic BioSciences ?
Gufic BioSciences share price is ₹190 As on 25 March, 2023 | 06:04
What is the Market Cap of Gufic BioSciences ?
The Market Cap of Gufic BioSciences is ₹1849.7 Cr As on 25 March, 2023 | 06:04
What is the P/E ratio of Gufic BioSciences ?
The P/E ratio of Gufic BioSciences is 22.6 As on 25 March, 2023 | 06:04
What is the PB ratio of Gufic BioSciences ?
The PB ratio of Gufic BioSciences is 6.9 As on 25 March, 2023 | 06:04